DESCRIPTION: Nicotine replacement therapy for smoking cessation has become
a popular mode of treatment with the advent of nicotine gum and, more
recently, transdermal nicotine (patch). Largely because of ease of
compliance and an improved adverse-effect profile, transdermal nicotine has
become the preferred method for pharmacological therapy. Whereas numerous
clinical trials have demonstrated the efficacy of the patch relative to a
placebo, the level of intensity of adjuvant counseling to achieve an
acceptable rate of cessation remains uncertain. The investigators propose a
study involving 1,900 smokers to be recruited to a randomized five-group
design involving different combinations of transdermal nicotine plus usual
care, telephone based counseling, or group-based counseling. Study
participants will be followed for 13 months to determine a treatment
outcome. Because treatment efficiency cannot be completely addressed
without consideration of patient-treatment interactions and adequate
valuations of the different treatment alternatives, the investigators also
propose to use analytic methods from clinical medicine and pharmacoeconomics
(cost-effectiveness analysis) to focus on these aspects of the overall
research question. This study will be conducted in collaboration with the
nation's largest health maintenance organization, Kaiser Permanente Medical
Care Plan (KPMCP) of Northern California.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.